Related Experiment Video
Updated: Aug 8, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Oncoprotein suppression of tumor necrosis factor-induced NF kappa B activation is independent of Raf-controlled
Julie L Hanson1, Vasiliki Anest, Julie Reuther-Madrid
1Lineberger Comprehensive Cancer Center, Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, 27599-7295, USA.
Abstract:
Extensive data indicate that the transcription factor NF kappa B is activated by signals downstream of oncoproteins such as Ras or breakpoint cluster region (BCR)-ABL. Consistent with this, evidence has been presented that NF kappa B activity is required for Ras and BCR-ABL to transform cells. However, it remains unclear whether these oncoproteins activate a full spectrum of NF kappa B-dependent gene expression or whether they may augment or interfere with other stimuli that activate NF kappa B. The data presented here indicate that BCR-ABL expression in 32D myeloid cells or oncogenic Ras expression in murine fibroblasts blocks the ability of tumor necrosis factor (TNF) to activate NF kappa B. This suppression of NF kappa B is manifested by an inhibition of TNF-induced inhibitor of NF kappa B (IKK) activity and NF kappa B DNA binding potential but not by blocking TNF-induced nuclear accumulation of NF kappa B/p65. The inhibition of NF kappa B is not observed in oncogenic Raf-expressing cells and is not fully restored by the suppression of PI3-kinase or MEK pathways. Oncogenic Ras suppresses the ability of TNF to activate the expression of NF kappa B-dependent genes, such as iNOS (inducible nitric oxide synthase) and RANTES (regulated on activation normal T-cell expressed and secreted). These studies suggest that the ability of Ras and BCR-ABL to activate NF kappa B involves an uncharacterized pathway that does not involve classic IKK activity and that suppresses the TNF-induced IKK pathway through a Raf/MEK/Erk-independent mechanism.
Insights
Oncoproteins like Ras and BCR-ABL block tumor necrosis factor (TNF)-induced activation of nuclear factor kappa B (NF kappa B) by inhibiting key signaling pathways. This interference affects NF kappa B-dependent gene expression, suggesting novel oncogenic mechanisms.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Oncology
Background:
- Oncoproteins such as Ras and BCR-ABL are known to activate the transcription factor NF kappa B.
- NF kappa B activity is crucial for cellular transformation mediated by these oncoproteins.
- It is not fully understood if these oncoproteins modulate the entire NF kappa B signaling network or interfere with other stimuli.
Purpose of the Study:
- To investigate whether Ras and BCR-ABL oncoproteins interfere with NF kappa B activation by other stimuli, specifically tumor necrosis factor (TNF).
- To elucidate the specific mechanisms by which these oncoproteins affect NF kappa B signaling downstream of TNF.
- To determine if the observed effects are dependent on known signaling pathways like Raf, PI3-kinase, or MEK.
Main Methods:
- Expression of BCR-ABL in 32D myeloid cells and oncogenic Ras in murine fibroblasts.
- Treatment with TNF to assess NF kappa B activation.
- Measurement of inhibitor of NF kappa B (IKK) activity, NF kappa B DNA binding, and nuclear translocation of NF kappa B/p65.
- Analysis of NF kappa B-dependent gene expression (iNOS, RANTES).
- Investigation of signaling pathways including Raf, PI3-kinase, and MEK.
Main Results:
- BCR-ABL and oncogenic Ras expression suppressed TNF-induced NF kappa B activation.
- This suppression involved inhibition of TNF-induced IKK activity and NF kappa B DNA binding, but not nuclear accumulation of NF kappa B/p65.
- The inhibitory effect was not observed in oncogenic Raf-expressing cells and was not fully rescued by inhibiting PI3-kinase or MEK.
- Oncogenic Ras reduced the expression of NF kappa B-dependent genes like iNOS and RANTES upon TNF stimulation.
Conclusions:
- Ras and BCR-ABL oncoproteins interfere with TNF-induced NF kappa B activation through a mechanism that does not involve canonical IKK activity.
- These oncoproteins suppress the TNF-induced IKK pathway via a Raf/MEK/Erk-independent route.
- The findings suggest an uncharacterized pathway utilized by Ras and BCR-ABL to modulate NF kappa B signaling, impacting oncogenic transformation.
Related Concept Videos
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

